Statistics for Ligand Pharmaceuticals (id:6455 LGND)
Valuation metrics
Market cap
2.11B
Enterprise value
1.90B
Trailing P/E (ttm)
44.85
Forward P/E
18.67
PEG ratio
18.67
Price/Sales (ttm)
13.84
Price/Book (mrq)
2.49
Enterprise Value/Revenue
12.46
Enterprise Value/EBITDA
36.08
Overview
Shares outstanding
18.90M
Float
18.52M
Shares short
918.63K
% Held by insiders
0.02%
% Held by institutions
1.00%
Average volume (10 days)
174.00K
Average volume (90 days)
Price summary
52-Week low
57.00
52-Week high
129.90
52-Week change
49.58%
Beta
0.90
50-Day moving average
107.17
200-Day moving average
90.38
Dividends and splits
Forward annual dividend rate
60.00
Forward annual dividend yield
0.50
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
July 02th, 2010
Last split factor
2:1
Last split date
November 02th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
29.68%
Operating margin
21.14%
Operational effectiveness
Return on assets
1.30%
Return on equity
6.00%
Income statement
Revenue (ttm)
8.51
Revenue per share (ttm)
8.51
Quarterly revenue growth (yoy)
Gross profit (ttm)
120.80M
EBITDA
51.22M
Net income to common (ttm)
45.24M
Diluted EPS (ttm)
2.49
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
219.64M
Total cash per share (mrq)
11.62
Total debt (mrq)
7.36M
Total Debt/Equity (mrq)
0.88
Current ratio (mrq)
1.25K%
Book value per share (mrq)
44.84
Cash flow
Cash flow statement
76.64M
Levered free cash flow (LFCF)
16.96M